Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.3988
H.R.3988: Generic Drug and Biosimilar User Fee Act of 2012
About This Bill
- This bill was introduced in the 112th Congress
- This bill is primarily about health
- Introduced Feb. 8, 2012
- Latest Major Action Feb. 10, 2012
Bill Sponsor
Bill Cosponsors
4 (3 Democrats, 1 Republican)
Bill Summary
Generic Drug and Biosimilar User Fee Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services (HHS), beginning FY2013, to assess and collect the following fees related to generic drugs: (1) a one-time backlog fee for abbreviated new drug applications pending on October 1, 2012; (2) a drug master file fee; (3) an abbreviated new drug application and prior approval supplement filing fee,...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Referred to the House Committee on Energy and Commerce.
|
|
|
Referred to the Subcommittee on Health.
|
|
| Feb. 8, 2012 |
Introduced in the House by Tim Murphy (R-Pa.) |